Elsevier

Metabolism

Volume 110, September 2020, 154298
Metabolism

Clinical Science
Population insulin sensitivity from sparsely sampled oral glucose tolerance tests

https://doi.org/10.1016/j.metabol.2020.154298Get rights and content

Highlights

  • Population estimates of insulin sensitivity have been useful to characterize different populations at high risk for diabetes.

  • The use surrogate measures of insulin sensitivity, such as HOMA-IR, while popular, remain controversial.

  • The population estimates of SI may be useful in the analysis of retrospective data where sparse sampling was employed.

Abstract

Objective

This work aimed to estimate population-level insulin sensitivity (SI) from 2-hour oral glucose tolerance tests (OGTT) with less than 7 samples.

Research design and methods

The current methodology combines the OGTT mathematical model developed by Dalla Man et al., with nonlinear multilevel (NLML) statistical model to estimate population-level insulin sensitivity (SI) from sparsely sampled datasets (3 or 4 samples per subject obtained in 120 min).

To validate our novel methodology of population SI estimation, we simulated 50 virtual subjects. We simulated 10 observations per subject over 240 minutes. After estimating their SI using the OGTT model, the virtual subjects were split into two groups, subjects with SI above the average and ones with below average. Subsequently, the simulated data were analyzed using statistical software and employing a t-test. The mean estimates of population SI for the two groups of virtual subjects and their respective 95% CI were compared to the estimates obtained with our novel NLML group SI estimates obtained using the 3 and 4 time points per subject.

To further validate the performance of the novel NLML model, a set of 34 prediabetic and 30 diabetic subjects with T2D was used. As outlined above for the in-silico subjects, differences between the prediabetic and T2D subjects in regard to SI was assessed using the classical two-stage approach (individual SI estimation followed by statistical comparison of the two groups). The average estimates obtained with the classical two-stage approach were compared to the group estimated obtained with the NLML approach using 3 (0, 60, and 120 minutes) points per subject obtained in 120 minutes.

Results

Unique and identifiable individual estimates of SI were obtained for all virtual subjects. In comparison to the subjects with above average SI (n=25), the subjects with simulated below average SI (n=25) exhibited significantly lower insulin sensitivity (P<0.001). Our novel NLML population model confirmed these findings (4-point OGTT: P<0.001; 3-point OGTT: P<0.001). In a similar fashion to the one outlined for the virtual subjects, the median insulin sensitivities estimated with the classical two-stage approach were different between the prediabetic (n=34) and T2D subjects (n=32, P=0.004). Using 3 points per subject, our novel NLML model confirmed these findings (P<0.001).

Conclusions

The population estimates of SI from OGTT data is an effective tool to assess population insulin sensitivity and assess differences that may not be possible when calculating individual SI or when less than 7 samples are available.

Introduction

Estimates of insulin sensitivity have been useful to characterize different populations at high risk for diabetes. Several methods exist to estimate insulin sensitivity. The gold standard for measurement of insulin sensitivity is the euglycemic-hyperinsulinemic clamp [1]. The minimal model [2] calculated from the frequently sampled intravenous glucose tolerance test (FSGTT) is another methodology that yields estimates of insulin sensitivity with a good correlation to the euglycemic-hyperinsulinemic clamp [3]. However, both the clamp and FSGTT are time-consuming, require multiple samples, and require steady-state for the clamp. Furthermore, the clamp and the FSGTT methods do not estimate insulin sensitivity in the physiologic state. They both measure insulin sensitivity in response to an intravenous rather than an oral stimulus of glucose.

Surrogate measures of insulin resistance, such as the HOMA-IR [4] and quantitative insulin sensitivity check index (QUICKI [5]) are easier to perform but based on fasting levels of glucose and insulin. HOMA-IR and QUICKI show reasonable correlation with euglycemic-hyperinsulinemic clamp in normal subjects, but each has failed to predict insulin sensitivity in subjects with impaired beta-cell function [6]. Thus, the use of these surrogate measures of insulin sensitivity remains controversial.

The oral glucose tolerance test (OGTT) remains the gold standard to diagnose diabetes and prediabetes. Since this is a more physiologic glucose stimulus, surrogate measures of insulin sensitivity using the OGTT have been developed. Underlying genotype-phenotype abnormalities can have different impact on fasting and postprandial glucose levels. The Matsuda index, a composite surrogate measure using 5 points from the OGTT, was developed to account for the heterogeneity of the diabetes phenotypes and have a broader measure of insulin sensitivity [7]. Another measure of insulin sensitivity from the OGTT is the oral minimal model by Dall Man et al [8]. The original model was developed using 20 samples over 300 minutes. A subsequent study showed that a 2-hour 7-sample OGTT correlates well with the 300 minutes 11-sample OGTT measurement of insulin sensitivity [9]. The oral minimal model is widely used. However, in most studies, especially those with large populations, a collection of 5- or 7-samples over 2 hours can be demanding on the research subject and may not be feasible in studies of large populations.

Our investigation aimed to develop a sparse sample method of measuring insulin sensitivity that will enable the use of the Dalla Man’s model in studies where less than 7 samples have been collected. When insufficient samples have been obtained per subject, a common practice in pharmacokinetic/pharmacodynamic (PK/PD) analysis has been to combine the data to yield a population model [10]. Population modeling extends the kinetic mathematical model to include fixed and random effects and, as such, are often known as mixed-effects models and can be nonlinear when the fixed part is not linear and referred as nonlinear mixed effects, NLME, models [11]. NLME models have previously been used to obtain estimates of minimal model parameters using FSGTT simulated sparse sampling data by using 13 samples from the FSGTT [12,13] and with 10 samples for estimation of Si from OGTT data [12]. These multiple samples are not feasible for large populations. Therefore, a quantitative estimate of insulin sensitivity that uses fewer time points during an OGTT and characterizes insulin sensitivity on a cohort level will be useful for studies assessing large numbers of people at high risk for type 2 diabetes.

Section snippets

Sparse sampling population non-linear multilevel modeling (NLML)

To obtain population estimates of all indices, we used NLML. In similar fashion to linear multilevel models for repeated measures, nonlinear models can be viewed as hierarchical models with fixed-effects level and random effects explaining a subject’s between and within variability. The “level” here refers to the individual sources of variance within the hierarchical organization of the data. For example, here we will specify a simple linear regression model in hierarchical or multilevel format

Simulated subjects

As outlined in the methods, we have generated simulated 50 virtual subjects that had varying levels of insulin sensitivity for the purpose of validating our novel NLML modeling methodology. Using 10 simulated samples of glucose and insulin per subject, we were able to obtain unique estimates of SI for each of the 50 “virtual” subjects with an average coefficient of variation (CV=16±3%). The mean insulin sensitivity for all 50 subjects was 3.73 (95% CI: 3.36 – 4.10) 10-4.μU/ml.min-1.

Discussion

In this article, we show that using our NLML population modeling approach on sparsely sampled OGTT data with only 3 samples per subject; we were able to detect changes in insulin sensitivity equivalent to previously quantified with the classical two-stage population modeling approach. Our methodology utilizes the Dalla Man’s OGTT model [8] and NLML population model to provide population estimates of SI. In contrast to previous approaches, our methodology does not provide individual estimates of

Acknowledgments

This work was funded by K08DK0830361 (D.D.S) and was supported by the National Center for Advancing Translational Sciences Award number (UL1TR002378) from the National Institutes of Health and National Research Resources.

References (26)

  • G.H.B. Nardotto et al.

    Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients

    Eur J Pharm Sci.

    (2017 Nov 15)
  • I.K. Martin et al.

    Application of the SAAM modeling program to minimal model analysis of intravenous glucose tolerance test data

    Comput Methods Programs Biomed.

    (1990 Dec)
  • R.A. DeFronzo et al.

    Glucose clamp technique: a method for quantifying insulin secretion and resistance

    Am J Physiol.

    (1979 Sep)
  • R.N. Bergman et al.

    Quantitative estimation of insulin sensitivity

    Am J Physiol.

    (1979 Jun)
  • J.C. Beard et al.

    The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values

    Diabetes

    (1986 Mar)
  • D.R. Matthews et al.

    Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man

    Diabetologia

    (1985 Jul)
  • A. Katz et al.

    Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans

    J Clin Endocrinol Metab.

    (2000 Jul)
  • A. Katsuki et al.

    Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus

    J Clin Endocrinol Metab.

    (2002 Nov)
  • M. Matsuda et al.

    Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp

    Diabetes Care.

    (1999 Sep)
  • C. Dalla Man et al.

    The oral glucose minimal model: estimation of insulin sensitivity from a meal test

    IEEE Trans Biomed Eng.

    (2002 May)
  • C. Dalla Man et al.

    Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals

    Diabetes.

    (2005 Nov)
  • C. Bon et al.

    Mathematical modeling and simulation in animal health. Part III: using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics

    J Vet Pharmacol Ther.

    (2018 Apr)
  • P. Denti et al.

    Nonlinear mixed effects to improve glucose minimal model parameter estimation: a simulation study in intensive and sparse sampling

    IEEE Trans Biomed Eng.

    (2009 Sep)
  • Cited by (2)

    • Fingertip capillary dynamic near infrared spectrum (DNIRS) measurement combined with multivariate linear modification algorithm for noninvasive blood glucose monitoring

      2021, Vibrational Spectroscopy
      Citation Excerpt :

      When the fluctuation range of blood glucose exceeds this range, it is diagnosed as diabetes or suspected diabetes [6]. It is considered that the most accurate way to diagnose diabetes is to monitor the fluctuation of blood glucose concentration for a certain period of time after a meal [7,8]. The Fasting Glucose Test (FGT) or the Oral Glucose Tolerance Test (OGTT) are the gold standard for the diagnosis of diabetes [9,10].

    1

    Contributed equal work.

    View full text